期刊文献+

高敏感C反应蛋白与冠心病病情及预后关系

Relationship between high sensitivity C-reaction protein and coronary heart diseases and its prognosis
下载PDF
导出
摘要 目的探讨高敏感C反应蛋白(HsCRP)与冠心病(CHD)病情及预后的关系。方法选择CHD患者78例(急性心肌梗死(AMI)36例、心绞痛(AP)42例),入院时测定HsCRP,并对所有患者发病后急性期、恢复期HsCRP进行动态监测,和健康对照组结果以及传统的心脑血管疾病危险因子血清总胆固醇(TC)进行比较。结果CHD患者HsCRP水平明显高于对照组(P<0.01),AMI患者HsCRP水平及HsCRP异常检出率明显高于AP患者,且都高于TC;AMI及AP患者发病后急性期HsCRP水平显著上升,恢复期又下降至发病初水平。结论HsCRP是独立的冠心病危险因子,其对冠心病的发生及预后有较好预报作用,对评价冠心病患者的疗效有较大参考价值。 Objective It is to study the relationship between high sensitivity C-reaction protein (HsCRP) and coronary heart diseases (CHD) and its prognosis. Methods 78 cases of patients with CHD including 36 cases with acute myocardial infarction (AMI) and 42 cases with angina pectoris were chosen and their HsCRP was measured when they were hospitalized. Then the levels of HsCRP were dynamicly determined during the acute phase and convalescent phase. The results were compared with those in control group and TC. Results The levels of HsCRP in patients with CHD were significantly higher than those in the control subjects( P〈 0.01 ). The levels and the positive rates of HsCRP was significantly higher in patients with AMI than those in patients with AP(P〈 0.01), and they were both higher than TC. The level of HsCRP rose in the acute phase of AMI or AP, either lowered to primal level in the convalescent phase. Conclusion HsCRP is an independent risk factor of CHD, and it has a good preventing function on the invasion and prognosis of CHD and a good referred value for evaluating the curative effect.
出处 《现代中西医结合杂志》 CAS 2006年第16期2168-2169,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 C反应蛋白 胆固醇 冠状动脉疾病 high sensitivity C- reactive protein total cholesterol coronary heart disease
  • 相关文献

参考文献8

  • 1Biasucci LM,Santamaria M,Liuzzo G.Inflammation,atherosclerosis and acute coronary syndromes[J].Minerva Cardioangiol,2002,50:475-486
  • 2Ridker PM,Cushman M,Stampfer MJ,et al.Plasma concerntration of C-reactive protein and risk of developing peripheral vascular disease[J].Circulation,1998,97(5):425-428
  • 3Patel VB,Robbins MA,Topol EJ.C-Reactive Protein:a "golden marker "for inflammation and coronary artery disease[J].Cleve Clin J Med,2001,68(6):521
  • 4陆敬辉,蔡秋艳,张瑞芳,过鑫昌,陈康妹.脂蛋白(a)及载脂蛋白B与冠心病各临床类型关系的探讨[J].上海医学检验杂志,1996,11(1):48-49. 被引量:17
  • 5王冬莲,吴春龙,陆如岳.冠心病患者脂质代谢指标与C反应蛋白联合检测的意义[J].中国免疫学杂志,2002,18(12):866-867. 被引量:5
  • 6Ridker PM,Hennekens CH,Buring JE,et al.C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J].N Engl J Med,2000,342(12):836-843
  • 7Ridker PM,Cook N.Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores[J].Circulation,2004,109(16):1955-1959
  • 8Libby P,Ridker PM,Maseri A.Inflammation and Atherosclerosis[J].Circulation,2002,105:1135

二级参考文献1

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部